Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EPTINEZUMAB-JJMR Cause Drug effect less than expected? 298 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 298 reports of Drug effect less than expected have been filed in association with EPTINEZUMAB-JJMR. This represents 4.2% of all adverse event reports for EPTINEZUMAB-JJMR.

298
Reports of Drug effect less than expected with EPTINEZUMAB-JJMR
4.2%
of all EPTINEZUMAB-JJMR reports
0
Deaths
8
Hospitalizations

How Dangerous Is Drug effect less than expected From EPTINEZUMAB-JJMR?

Of the 298 reports, 8 (2.7%) required hospitalization.

Is Drug effect less than expected Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EPTINEZUMAB-JJMR. However, 298 reports have been filed with the FAERS database.

What Other Side Effects Does EPTINEZUMAB-JJMR Cause?

Drug ineffective (1,779) Migraine (1,235) Headache (821) Therapeutic response shortened (449) Nausea (435) Fatigue (413) Throat irritation (290) Dizziness (279) Pruritus (245) Nasal congestion (207)

What Other Drugs Cause Drug effect less than expected?

DUPILUMAB (1,204) DICLOFENAC (647) VEDOLIZUMAB (461) PRABOTULINUMTOXINA-XVFS (354) OFATUMUMAB (319) IBUPROFEN (218) TOFACITINIB (210) SECUKINUMAB (190) ACETAMINOPHEN\IBUPROFEN (163) ACETAMINOPHEN\ASPIRIN\CAFFEINE (134)

Which EPTINEZUMAB-JJMR Alternatives Have Lower Drug effect less than expected Risk?

EPTINEZUMAB-JJMR vs EPTINEZUMAB\EPTINEZUMAB-JJMR EPTINEZUMAB-JJMR vs EQUINE THYMOCYTE IMMUNE GLOBULIN EPTINEZUMAB-JJMR vs ERAVACYCLINE EPTINEZUMAB-JJMR vs ERBITUX EPTINEZUMAB-JJMR vs ERDAFITINIB

Related Pages

EPTINEZUMAB-JJMR Full Profile All Drug effect less than expected Reports All Drugs Causing Drug effect less than expected EPTINEZUMAB-JJMR Demographics